Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort

Respiratory Medicine

Volumn 107, Issue 9, 2013, Pages 1376-1384

  Miller, Joy ^a   Edwards, Lisa D ^b   Agustí, Alvar ^c   Bakke, Per ^d   Calverley, Peter M A ^e   Celli, Bartolome ^f   Coxson, Harvey O ^g   Crim, Courtney ^b   Lomas, David A ^h   Miller, Bruce E ^b   Rennard, Steve ⁱ   Silverman, Edwin K ^f   Tal Singer, Ruth ^b   Vestbo, Jørgen ^j,k   Wouters, Emiel ^l   Yates, Julie C ^b   Macnee, William ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b GLAXOSMITHKLINE   (United States)

^c UNIVERSITY OF BARCELONA   (Spain)

^d UNIVERSITY OF BERGEN   (Norway)

^e UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^h UNIVERSITY OF CAMBRIDGE   (United Kingdom)

ⁱ UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^j UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^k UNIVERSITY OF MANCHESTER   (United Kingdom)

^l MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

more..

Author keywords

Cardiovascular disease; Chronic obstructive pulmonary disease; Cigarette smoking; Diabetes; Emphysema; Osteoporosis

Indexed keywords

FIBRINOGEN; INTERLEUKIN 6; INTERLEUKIN 8;

ADULT; AGED; ANXIETY; ARTICLE; CARDIOVASCULAR MORTALITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSPNEA; FEMALE; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; INFLAMMATION; ISCHEMIC HEART DISEASE; LONGITUDINAL STUDY; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OSTEOPOROSIS; OUTCOMES RESEARCH; PANIC; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; SCORING SYSTEM; SMOKING;

CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE PULMONARY DISEASE; CIGARETTE SMOKING; DIABETES; EMPHYSEMA; OSTEOPOROSIS;

ADULT; AGED; COMORBIDITY; DIABETES COMPLICATIONS; FEMALE; HEART DISEASES; HUMANS; HYPERTENSION; INFLAMMATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OSTEOPOROSIS; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; SMOKING;

EID: 84883053051     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2013.05.001     Document Type: Article

References (35)

1. B. Celli, and W. MacNee Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper Eur Respir J 23 6 2004 932 946
2. E.P. Havranek, F.A. Masoudi, K.A. Westfall, P. Wolfe, D.L. Ordin, and H.M. Krumholz Spectrum of heart failure in older patients: results from the National Heart Failure project Am Heart J 143 3 2002 412 417
3. N.R. Anthonisen, J.E. Connett, P.L. Enright, J. Manfreda, and L.H.S.R. Group Hospitalizations and mortality in the lung health study Am J Respir Crit Care Med 166 3 2002 333 339
4. D. Sin, and S. Man Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease Circulation 107 11 2003 1514 1519
5. A.L. Hansell, J.A. Walk, and J.B. Soriano What do chronic obstructive pulmonary disease patients die from? A multiple cause coding analysis Eur Respir J 22 5 2003 809 814
6. D.D. Sin, J.P. Man, and S.F. Man The risk of osteoporosis in caucasian men and women with obstructive airways disease Am J Med 114 2003 10 14
7. F. Di Marco, M. Verga, M. Reggente, F. Maria Casanova, P. Santus, and F. Blasi Anxiety and depression in COPD patients: the roles of gender and disease severity Respir Med 100 10 2006 1767 1774
8. D.M. Mannino, S.M. Aguayo, T.L. Petty, and S.C. Redd Low lung function and incident lung cancer in the United States: data from the first national health and nutrition examination survey follow-up Arch Intern Med 163 12 2003 1475 1480
9. J.S. Rana, M.A. Mittleman, J. Sheikh, F.B. Hu, J.E. Manson, and G.A. Colditz Chronic obstructive pulmonary disease, asthma, and risk of type 2 diabetes in women Diabetes Care 27 10 2004 2478 2484
10. W.M. Chatila, B.M. Thomashow, O.A. Minai, G.J. Criner, and B.J. Make Comorbidities in chronic obstructive pulmonary disease Proc Am Thorac Soc 5 4 2008 549 555
11. D.M. Mannino, D. Thorn, A. Swensen, and F. Holguin Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD Eur Respir J 32 4 2008 962 969
12. J.R. Feary, L.C. Rodrigues, C.J. Smith, R.B. Hubbard, and J.E. Gibson Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care Thorax 65 11 2010 956 962
13. R. Nielsen, A. Johannessen, E.R. Omenaas, P.S. Bakke, J.E. Askildsen, and A. Gulsvik Excessive costs of COPD in ever-smokers. A longitudinal community study Respir Med 105 3 2011 485 493
14. A. Sharafkhaneh, N.J. Petersen, H.-J. Yu, A.A. Dalal, M.L. Johnson, and N.A. Hanania Burden of COPD in a government health care system: a retrospective observational study using data from the US veterans affairs population Int J COPD 5 2010 125 132
15. F. Luppi, F. Franco, B. Beghé, and L. Fabbri Treatment of chronic obstructive pulmonary disease and its comorbidities Proc Am Thorac Soc 5 8 2008 848 856
16. C. Vogelmeier, and E.M. Wouters Treating the systemic effects of chronic obstructive pulmonary disease Proc Am Thorac Soc 8 2011 376 379
17. H. Magnussen, and H. Watz Systemic inflammation in chronic obstructive pulmonary disease and asthma: relation with comorbidities Proc Am Thorac Soc 6 2009 648 651
18. L.M. Fabbri, and K.F. Rabe From COPD to chronic systemic inflammatory syndrome? Lancet 370 9589 2007 797 799
19. J. Vestbo, W. Anderson, H. Coxson, C. Crim, F. Dawber, L. Edwards ECLIPSE investigators Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-Points (ECLIPSE) Eur Respir J 31 2008 869 873
20. A. Agusti, P.M.A. Calverley, B. Celli, H.O. Coxson, L.D. Edwards, D.A. Lomas Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators Characterisation of COPD heterogeneity in the ECLIPSE cohort Respir Res 11 2010 122 136
21. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society Am J Respir Crit Care Med 152 5 Pt 2 1995 S77 S121
22. ATS statement: guidelines for the six-minute walk test Am J Respir Crit Care Med 166 1 2002 111 117
23. P. Quanjer, G.J. Tammeling, J.E. Cotes, O.F. Pedersen, R. Peslin, and J. Yernault Lung volumes and forced ventilatory flows. Report Working Party Standardization of lung function tests, European community for Steel and Coal. Official statement of the European respiratory Society Eur Respir J Suppl 16 1993 5 40
24. B. Celli, C. Cote, J. Marin, C. Casanova, M. Montes de Oca, and R. Mendez The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease N Engl J Med 350 10 2004 1005 1012
25. D.A. McAllister, J.D. Maclay, N.L. Mills, G. Mair, J. Miller, and D. Anderson Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 176 12 2007 1208 1214
26. N.L. Mills, J.J. Miller, A. Anand, S.D. Robinson, G.A. Frazer, and D. Anderson Increased arterial stiffness in patients with chronic obstructive pulmonary disease: a mechanism for increased cardiovascular risk Thorax 63 4 2008 306 311
27. J.D. Maclay, D.A. McAllister, and W. MacNee Cardiovascular risk in chronic obstructive pulmonary disease Respirology 12 5 2007 634 641
28. G. Arunachalam, I.K. Sundar, J.-W. Hwang, H. Yao, and I. Rahman Emphysema is associated with increased inflammation in lungs of atherosclerosis-prone mice by cigarette smoke: implications in comorbidities of COPD J Inflamm (Lond) 7 2010 34
29. M. Dahl, A. Tybjaerg-Hansen, J. Vestbo, P. Lange, and B.G. Nordestgaard Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease Am J Respir Crit Care Med 164 6 2001 1008 1011
30. W. Gan, S. Man, and D. Sin The interactions between cigarette smoking and reduced lung function on systemic inflammation Chest 127 2 2005 558 564
31. G.C. Donaldson, T.A.R. Seemungal, I.S. Patel, A. Bhowmik, T.M.A. Wilkinson, and J.R. Hurst Airway and systemic inflammation and decline in lung function in patients with COPD Chest 128 4 2005 1995 2004
32. J. Vestbo, L.D. Edwards, P.D. Scanlon, J.C. Yates, A. Agusti, P. Bakke ECLIPSE Investigators Changes in forced expiratory volume in 1 second over time in COPD N Engl J Med 365 2011 1184 1192
33. M. Dahl, J. Vestbo, P. Lange, S. Bojesen, A. Tybjaerg-Hansen, and B. Nordestgaard C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease Am J Respir Crit Care Med 175 3 2007 250 255
34. M. Dahl, and B.G. Nordestgaard Markers of early disease and prognosis in COPD COPD 4 1 2009 157 167
35. D.P. Tashkin, B. Celli, S. Senn, D. Burkhart, S. Kesten, S. Menjoge UPLIFT Study Investigators A 4-year trial of tiotropium in chronic obstructive pulmonary disease N Engl J Med 359 15 2008 1543 1554